Healthcare investor Syncona welcomed news that portfolio company Achilles Therapeutics had priced a US initial public offering to raise around $175.5 million (£127.8 million).
Russia-focused gold miner Petropavlovsk forecast a fall in annual production and said it was undertaking a sweeping review of its business to cut costs.